Reply to comment on: “Advantages of bevacizumab for aggressive posterior retinopathy of prematurity”

por Schechet, Sidney A., Rodriguez, Sarah Hilkert, Shapiro, Michael J., Blair, Michael P.
Publicado 2019

Bevacizumab or laser for aggressive posterior retinopathy of prematurity

por Blair, Michael, Gonzalez, Jose Maria Garcia, Snyder, Laura, Schechet, Sidney, Greenwald, Mark, Shapiro, Michael, Rodriguez, Sarah Hilkert
Publicado 2018